A network for sharing data and resources in immuno-oncology.
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-9889667 on NIH RePORTER |
What this research studies
This research focuses on enhancing the clinical use of immuno-oncology strategies by fostering collaboration among experts to understand cancer resistance mechanisms, discover new immune targets, and identify predictive biomarkers. It aims to evaluate combination therapies and develop preventive approaches for cancer in adults. The project will serve as a central hub for data management and analysis, ensuring high standards in data collection and supporting a collaborative research environment. Patients may benefit from improved treatment options and personalized therapies derived from this collaborative effort.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are affected by cancer or at risk of developing cancer.
Not a fit: Patients with non-malignant conditions or those under 21 years old may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and preventive strategies for patients.
How similar studies have performed: Previous research in immuno-oncology has shown promising results, indicating that collaborative approaches can lead to significant advancements in cancer treatment.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.